Selected cell envelope components of Porphyromonas gingivalis were tested in a BALB/c mouse model in an attempt to elucidate further the outer membrane components of this putative oral pathogen that might be considered as virulence factors in host tissue destruction. Lipopolysaccharide (LPS), outer membrane, and outer membrane vesicles of P. gingivalis W50, ATCC 53977, and ATCC 33277 were selected to examine an immunological approach for interference with progressing tissue destruction. Mice were actively immunized with heat-killed (H-K) or Formalin-killed (F-K) whole cells or with the outer membrane fraction, LPS, or outer membrane vesicles of the invasive strain P. gingivalis W50. The induction of invasive spreading lesions with tissue destruction and lethality were compared among different immunization groups in normal, dexamethasone-treated (dexamethasone alters neutrophil function at the inflammatory site), and galactosamine-sensitized (galactosamine sensitization increases endotoxin sensitivity) mice after challenge infection with the homologous strain (W50) and heterologous strains (ATCC 53977 and ATCC 33277). Enzyme-linked immunosorbent assay analyses revealed significantly elevated immunoglobulin G and M antibody responses after immunization with H-K or F-K cells or the outer membrane fraction compared with those of nonimmunized mice. The killed whole-cell vaccines provided significantly greater protection against challenge infection in normal mice (decreased lesion size and death) than did either the outer membrane fraction or LPS immunization. The lesion development observed in dexamethasone-pretreated mice was significantly enhanced compared with that of normal mice after challenge with P. gingivalis. Immunization with P. gingivalis W50 provided less protection against heterologous challenge infection with P. gingivalis ATCC 53977; however, some species-specific antigens were recognized and induced protective immunity. Only viable P. gingivalis induced a spreading lesion in normal, dexamethasone-treated, or galactosamine-sensitized mice; F-K or H-K bacteria did not induce lesions. The F-K and outer membrane vesicle immunization offered greater protection from lesion induction than did the H-K immunogen after challenge infection simultaneous with galactosamine sensitization. The H-K cell challenge with galactosamine sensitization produced 100% mortality without lesion induction, suggesting that LPS or LPS-associated outer membrane molecules were functioning like endotoxin. Likewise, P. gingivalis W50 LPS (1 ,ug per animal) administered intravenously produced 80%o mortality in galactosamine-sensitized mice. In contrast to the effects of immunization on lesion development, immunization with H-K or F-K cells or LPS provided no protection against intravenous challenge with LPS; 100% of the mice died from acute endotoxin toxicity. These findings suggest that the murine model will be useful in examining the tissuedestructive components of P. gingivalis.
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Porphyromonas gingivalis, which is frequently implicated in chronic and severe adult periodontitis (40) , possesses a variety of virulence factors that may contribute to the destructive events of periodontitis (18, 19, 29) . In addition to a large number of proteolytic enzymes, P. gingivalis elaborates a lipopolysaccharide (LPS) that affects both immune and nonimmune mammalian cells (14, 18, 21 ) and outer membrane blebs (i.e., outer membrane vesicles [OMVs] ), which contain, in addition to LPS and outer membrane proteins, other toxic molecules (i.e., proteolytic enzymes and porins) that affect the integrity of the periodontium (18, 28, 29, 39) .
Although a large number of reports have described significant elevations in levels of specific serum immunoglobulin G (IgG) antibody to P. gingivalis infection in patients with adult and advanced destructive periodontitis and in the gingival crevicular fluids from these patients (9, 11, 27, 32, 40) (23) , and antigenic components from P. gingivalis W50 and W83, suggesting a substantial homology. We therefore felt justified in using P. gingivalis W83 LPS in the studies described in this report.
(ii) Cell envelope fraction. A cell envelope fraction was isolated from P. gingivalis W50 by mechanical disruption (3) . Whole cells were sedimented by centrifugation at 15,000 x g for 20 min and washed twice with 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer (pH 7.4). The pellet was resuspended to a final concentration of 1 g of wet weight in 3 ml of 10 mM HEPES. These cells were mixed with 50 17 ,000 lb/in2 until >90% cell breakage was observed under phase microscopy of wet-mount preparations. After whole cells and debris were removed by centrifugation at 5,000 x g for 20 min at 4°C, the supernatant was centrifuged at 100,000 x g for 1 h at 4°C to obtain a cell envelope fraction. The cell envelope fraction was resuspended in 20 ml of 1% (wt/vol) sodium N-lauryl sarcosinate (Sigma Chemical Co., St. Louis, Mo.) for each g (wet weight) of the original bacterial pellet and mixed gently for 30 min at room temperature. The resulting preparation was again centrifuged at 100,000 x g for 1 h at 4°C to concentrate the OMF. This OMF was washed once with 10 mM HEPES and further solubilized in 2% (wt/vol) sodium lauryl sulfate by sonication at ice bath temperature. The resulting solubilized OMF was adjusted to a protein content of 2 mg/ml (BCA assay) and stored at -70°C until used.
Preparation of OMVs. OMVs were prepared from P. gingivalis W50 by the method of Grenier and Mayrand (16) by using (NH4)2SO4 (50% [wt/vol] saturation of the culture fluid at 4°C) after sedimentation of the whole cells at 16,000 x g for 30 min. The OMVs were resuspended in sterile PBS and stored at -70°C until used. The protein content was determined by using the BCA assay.
Animals. The BALB/c female mice (Charles River Laboratories, Willmington, Mass.) used in these studies were generally 6 to 12 weeks old when they were tested for bacterial virulence. The Virulence of P. gingivalis after active immunization. As reported previously by us (10) , the dynamics of lesion development in s.c. injected BALB/c mice included the formation of recognizable lesions at approximately 18 h and death, when it occurred, by 2 to 3 days postchallenge. In surviving mice, lesion regression and resolution occurred by 15 days. Therefore, this time frame was utilized in the experiments described in this report.
Normal BALB/c mice immunized with H-K or F-K whole cells, OMF, LPS, or placebo were examined for immune responses that ameliorated lesion formation (Fig. 2) . At 2 weeks postimmunization, the animals were challenged with 5 x 101 , 2 x 101o, or 1 x 1010 P. gingivalis W50 cells. Within 18 h after P. gingivalis W50 challenge, all placebo (IFA)-immunized control animals developed a dose-dependent spreading P. gingivalis lesion, particularly at P. gingivalis doses of 5 x 0l and 2 x 1010 (Fig. 2) . This lesion spread laterally and ulcerated the entire abdomen and was accompanied by severe cachexia; death routinely followed. In contrast, H-K and F-K whole-cell-immunized animals exhibited a moderate spreading lesion by 18 to 72 h with minimal cachexia (data not shown). Compared with placebo-immunized mice, both H-K and F-K whole-cell-immunized animals showed a highly significant decrease in induction of a spreading lesion at all challenge doses. Lesion formation was not observed in 20% of the H-K-immunized animals challenged with 2 x 1010 P. gingivalis whole cells. Also apparent was that the killed whole-cell vaccines (F-K, H-K) provided better protection (i.e., smaller lesion size and lower percentage of death; see below) than did immunization with either OMF or LPS. However, the OMF-and LPS-immunized animals did show a significant decrease in the induction of the spreading lesion compared with that of the placebotreated animals (Fig. 2) .
The effect of immunization with P. gingivalis H-K and F-K cells, LPS, and OMF on BALB/c mice with altered neutrophil capabilities (DEX treatment) is shown in Fig. 3 . Compared with placebo immunization at the highest P. also had a minimal effect on lesion size in the OMF-and LPS-immunized mice compared with that in placebo animals (Fig. 4) . H-K and F-K whole-cell immunization therefore afforded less protection in the DEX-treated animals than the placebo (IFA)-immunized animals. OMF and LPS immunization, on the other hand, appeared to have a similar effect in the presence or absence of normal neutrophil capacity (i.e., with or without DEX). Placebo-treated animals with and without DEX treatment developed large spreading lesions after challenge with 5 x 10'0 P. gingivalis W50 cells; 100% of the mice died (Fig. 4 ). F-K and H-K whole-cell immunization reduced the lethal effects of this high P.
gingivalis challenge by 60% in the DEX-treated group (two of five animals died), whereas lethal effects were completely so 2~~~. S1.. ATCC 33277. Although immUtnization with H-KP. gingivalis W50 protected the P. gingivalis ATCC 53977-challenged animals from lesion formation, it only resulted in a 30% reduction in lesion size. The lesions induced by heterologous challenge with P. gingivalis ATCC 53977 were significantly larger than those induced by homologous challenge with P. gingivalis W50 in H-K-, F-K-, and LPS-immunized mice. Immunization with the P. gingivalis W50 OMV also provided protection from lesion formation induced by P. gingivalis W50 and ATCC 53977 (IFA-injected animals were used as controls). P. gingivalis ATCC 33277 challenge had essentially no effect; however, this strain also produced a very small lesion in the placebo-immunized animals. P. gingivalis W50 LPS immunization afforded only partial protection in mice challenged with homologous P. gingivalis W50; however, it did not protect animals challenged with P. gingivalis ATCC 53977 or ATCC 33277 from lesion formation. Immunization of mice with P. gingivalis W50 H-K and F-K cells also resulted in a significant decrease in lesion size in mice challenged with P. gingivalis ATCC 33277 (Fig. 5) . The mortality associated with homologous or heterologous P. gingivalis challenge is seen in Table 1 . P. gingivalis infection indicated a graded difference in the degree of cross-immune protection, such that F-K = OMV > H-K > LPS, after heterologous P. gingivalis ATCC 53977 challenge infection; the relative immune protection to homologous P. gingivalis W50 challenge infection was F-K = H-K > OMV > LPS ( Table 1) .
Effect of challenge with viable or killed P. gingivalis W50 in normal, DEX-treated, and GalN-sensitized mice. Nonimmunized animals treated with DEX or sensitized with GalN were challenged with 2 x 1010 viable P. gingivalis W50 cells; spreading lesions formed in the normal, DEX-treated, and GalN-sensitized mice (Fig. 6 ). H-K P. gingivalis W50 challenge with simultaneous GalN sensitization also resulted in 100% lethality by 18 h without lesion formation, indicating that one component of the H-K antigen is a heat-stable endotoxin. In contrast, injection of H-K P. gingivalis W50 induced no morbidity or mortality in normal and DEXtreated mice. Challenge with 2 x 1010 F-K P. gingivalis W50 cells resulted in neither the formation of spreading lesion nor death in any of the animal groups (Fig. 6) , suggesting that Formalin modified or altered the lethal activity of the P. gingivalis W50 LPS or other contributing bacterial components.
Immune protection in GaIN-sensitized mice. Since the above findings suggested that the P. gingivalis W50 LPS contributed to mouse lethality, mice were actively immunized with P. gingivalis W50 H-K and F-K whole cells, OMV, or LPS to determine the ability of these antigens to induce immunological interference with the LPS-mediated toxicity (Fig. 7) . Both IgG and IgM antibodies were produced against the P. gingivalis WSO LPS (data not shown). Both F-K-and OMV-immunized animals had significantly greater (P < 0.025) protection from lesion development than did the H-K-immunized animals after challenge with viable P. gingivalis W50. The protection provided by immunization with the P. gingivalis W50 LPS in mice challenged with viable P. gingivalis W50 was significantly less than that INFECT. IMMUN. provided by any of the other immunogens. When similarly immunized animals were challenged with five times (5 ,ug per animal) the concentration of a normal lethal dose of P. gingivalis W50 LPS, OMV was the only antigen that partially protected (60% mortality) mice against LPS challenge (Fig. 7) .
DISCUSSION
Even though numerous studies (40) have established the participation of a small number of microorganisms in human periodontal disease (18, 40) , there are only a few studies that have explored the longitudinal events (i.e., clinical, microbiological, immunological) that occur during disease progression in humans. To more accurately document the characteristics of disease progression, investigators have used several animal models (10, 13, 20, 22, 48) . The most prominent model is the primate model pioneered by Komman et al. (26) and extended by Holt et al. (20) . McArthur et al. (30) and Nisengard and coworkers (34) also provided evidence that the primate is an important animal model for the study of periodontal disease progression.
Although it has been verified that the primate is an excellent system for the study of disease progression, it has been difficult to design useful experiments with these animals in an attempt to understand the in vivo pathogenic activity of several of the putative periodontal pathogens (18, 19) . The advances in understanding the in vivo pathogenesis (i.e., virulence) of these oral microorganisms (i.e., P. gingivalis, Actinobacillus actinomycetemcomitans, and Wolinella recta) have emerged from the rodent model (10, 22, 29, 43, 49) . These murine models have been used to measure the effects of these periodontal disease-related bacteria on rodent morbidity and mortality. Several of these models have also studied the effects of LPS, OMVs, and outer membranes on virulence. These in vivo mouse-periodontal pathogen interactions were also observed by several investigators who studied the mitogenic effects of these bacteria. In addition to activating murine macrophages, lymphocytes, and other immune system components, P. gingivalis produces significant amounts of a large variety of proteolytic enzymes (25) . We know very little of the elaboration of these proteolytic-hydrolytic molecules in the in vivo environment of the rodent. Since P. gingivalis produces spreading, phlegmonous lesions in the rodent model (22, 48) and since, depending upon the numbers of pathogens and lesion integrity, the outcome can be fatal, it is essential to understand the contribution of this important oral bacterium to tissue and bone destruction. Hence, it is important to study the role of these microorganisms in the production of these extensive, phlegmonous lesions in P. gingivalis-infected mice. It is not possible to translate the findings in the rodent to the progression of human periodontal disease. All that is possible is an understanding of the high virulence of these bacteria in a rodent host.
In addition to the study presented here, there are only two other published studies that have investigated the ability of actively acquired immune responses to P. gingivalis or selected surface components to interfere with P. gingivalis pathogenesis (i.e., abscess formation) in this rodent model (5, 6) . These latter studies utilized immunogens restricted to pasteurized P. gingivalis 381 and A7A1-28, Prevotella intermedia, and a lithium diiodosalicylate cell surface extract and the LPS from P. gingivalis A7A1-28 (ATCC 53977). Although the lithium diiodosalicylate cell surface extract provided strain-specific immune protection, its complex nature was not useful in determining which components within it were the effective immunogens. The present study more clearly detailed several of the potential components of the P. gingivalis surface that might be involved in tissue destruction and lethal outcome associated with P. gingivalis infections. We immunization with F-K and H-K P. gingivalis whole cells elicited a classical elevation in serum IgG and IgM antibodies that reacted with intact bacteria. Since the H-K antigen reacted with more antibody molecules than did the F-K antigen, it is possible that the differences in protection were due to differences in antigenic composition or to an increased antigen epitope expression present in the H-K whole-cell test antigen.
Although cross-sectional immunological studies of sera from periodontitis patients have demonstrated high titers of antibody to P. gingivalis LPS (38) , fimbriae (50) , and outer membrane proteins (1), there are no data indicating that the antibodies to these specific P. gingivalis surface molecules are actually protective by interfering with or neutralizing the activity of these components in vivo. In fact, our observations revealed that the P. gingivalis W50 immunogens used in our experiments (F-K and H-K whole cells, LPS, OMF) only partially protected the animals from lesion formation by the homologous P. gingivalis strain. These observations suggest that surface molecules other than LPS and outer membrane proteins (i.e., proteolytic enzymes) are involved in lesion formation. Kesavalu et al. (25) have preliminary evidence that trypsin-deficient mutants of P. gingivalis produced only small localized lesions, unlike the spreading lesions elicited by the parental wild-type strain. Immunization with F-K P. gingivalis did provide the greatest protection from lesion formation by this pathogen (Fig. 2 and 4) . Previous findings in other infection models have suggested that this type of vaccine (i.e., F-K whole cells) can elicit an efficient protective immune response (2) . The H-K P. gingivalis immunogen was not as effective as the F-K immunogen in ameliorating lesion initiation (compare Fig. 2 and 4) , suggesting that heating of the whole cells modified or altered protective protein epitopes and permitted the presentation of only, for example, heat-stable polysaccharides of the P. gingivalis capsule or the O-polysaccharide of the LPS for antibody induction. These latter molecules were not involved in lesion formation, since antibody production against them was not protective. These findings are also consistent with the previous observations that LPS is not a vital component in the production of lesions by P. gingivalis (5) .
Previous studies suggested that the immune protection afforded by immunization with P. gingivalis whole cells was strain specific (6). Other reports also described a variability in lesion formation by different P. gingivalis strains (17, 22, 33, 47) . The results presented in this report demonstrate that P. gingivalis ATCC 33277, ATCC 53977, and W50 are in fact very different in their ability to induce a lesion in BALB/c mice. The lesions produced by P. gingivalis ATCC 53977 and W50 in mice were significantly larger than those produced by P. gingivalis 33277. Previous immunologic protection studies (5, 6) are in agreement with our observations that active immunization with P. gingivalis strains or their components produced significantly greater immunological protection in the homologous system. However, although the homologous immunization system produced the greatest protection against lesion formation and death, our observations demonstrated clear immunologic cross-reactivity, because lesions caused by P. gingivalis ATCC 53977 or ATCC 33277 were diminished in size after heterologous challenge compared with those of the placebo-injected group (Fig. 5) . Thus, although the P. gingivalis strains used in this study represent three different serotypes (13) , it appears that species-specific antigens are also present and that inhibition of these components by an antibody can result in decreased disease expression.
Antibodies protect the host against microbial and viral pathogenesis by inhibiting the ability of the invading organism to enter the host and successfully colonize it (30, 34) . Antibodies also protect the host by fixing complement, neutralizing toxins, opsonizing invading bacteria, and providing a significant advantage for cell-mediated events (i.e., phagocytosis). Neutrophils are therefore essential to the host in interfering with disease progression (46) . However, whether neutrophil function is dependent upon antibodies (opsonization) has not been delineated in the rodent model of P. gingivalis virulence. Although we clearly showed that the immune response to P. gingivalis whole cells or cell surface components was related to antibody elicited in these animals and provided a measure of protection, it was not clear how this antibody functioned in host protection. We addressed the question of the role of the neutrophil in protection against lesion formation and lethality by lowering the neutrophil population infiltrating the local lesion by treating the animals with DEX (12, 35) . Although the antibody to any of these immunogens decreased both lesion size and lethal outcome in the absence of normal neutrophil levels at the site of infection, after treatment with DEX the virulence of the P. gingivalis strains was significantly enhanced (Fig. 6) .
Thus, it appears that in this model system the antibody is functioning primarily as an opsonin to bind to bacteria or their products and enable phagocytic destruction of the virulence components. The DEX reduction of the local neutrophil content in the presence of sufficient antibody strongly suggests an opsonic effect of the elicited antibody.
Finally, the question of whether live (viable) or dead (i.e., F-K, H-K) P. gingivalis cells were required for lesion formation and lethality and the endotoxicity of the P. gingivalis LPS was also addressed in these studies. Comparison of normal and DEX-treated mice convincingly demonstrated that lesion formation and lethality required viable P. gingivalis (Fig. 6) . Similarly, the endotoxic potential of the P. gingivalis LPS was examined in mice by utilizing the GalN sensitization model of Galanos et al. (15, 24) , which permits LPSs of even very low endotoxicity to be studied in an exquisitely sensitive in vivo system. We were able to demonstrate that simultaneous injection of GalN with LPS or whole cells of P. gingivalis W50 enhanced the morbidity caused by these agents in mice (Fig. 7) . Additionally, active immunization with H-K and F-K P. gingivalis and OMVs significantly ameliorated lesion progression. In contrast, immunization with LPS had only a minimal effect on lesion size, whereas GalN sensitization of mice intravenously challenged with LPS provided no protection against lethal events induced by the LPS (Fig. 7) . Thus, it appears that in GalN-sensitized mice LPS is not a critical component for spreading lesion progression; however, it is critical in lethality in this murine model. Therefore, the P. gingivalis LPS does possess endotoxic activity. The formation of lesions in all of the immunized animals (although the lesions were significantly smaller) in this study indicated clearly that the elicited immune response with all the antigens tested was not capable of completely abrogating lesion formation but could eliminate mortality. Thus, it would appear that these two disease outcomes are regulated by different pathogenic mechanisms of this microorganism.
